Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Sites / University of California Irvine / Mercola, Dan

Mercola, Dan (M.D., Ph.D.)

PI, University of California Irvine, 949-824-1298

Contact Information

Email: mailto:dmercola@uci.edu
Fax:
EDRN Associate Member

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
The Prostate Tumor Microenvironment Exhibits differentially expressed Genes Useful for Diagnosis 348 0
Upgrading Reference Set 0 0

Closed Protocols

Protocol Name Biomarkers Datasets
Prostate Upgrading Team Project 0 0

Publications

Publication Name PubMed ID Journal
Diagnosis of prostate cancer using differentially expressed genes in stroma. 21459804 Cancer Res.
Prostate cancer postoperative nomogram scores and obesity. 21390220 PLoS ONE
Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. 23091600 PLoS ONE
An accurate prostate cancer prognosticator using a seven-gene signature plus Gleason score and taking cell type heterogeneity into account. 23028830 PLoS ONE
TGF-β mediated DNA methylation in prostate cancer. 25133096 Transl Androl Urol
A sample selection strategy to boost the statistical power of signature detection in cancer expression profile studies. 22934703 Anticancer Agents Med Chem
Modeling the width and placement of riparian vegetated buffer strips: a case study on the Chi-Jia-Wang stream, Taiwan. 12448405 J. Environ. Manage.
In silico estimates of tissue components in surgical samples based on expression profiling data. 20663908 Cancer Res.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Addresses

843 Health Science Rd
University of California, Irvine

To update addresses, please visit the Data Management and Coordinating Center.

Announcement 03/14/2018
Thank you to everyone to made the 10th EDRN Scientific Workshop a success. The next event is the 33rd EDRN Steering Committee Meeting from September 5-6, 2018 in Boston, MA. Details will be available soon.


Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.

Announcement 10/23/2017

Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.

EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.